These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16024879)

  • 1. Neurophysiological predictors of long term response to AChE inhibitors in AD patients.
    Di Lazzaro V; Oliviero A; Pilato F; Saturno E; Dileone M; Marra C; Ghirlanda S; Ranieri F; Gainotti G; Tonali P
    J Neurol Neurosurg Psychiatry; 2005 Aug; 76(8):1064-9. PubMed ID: 16024879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rivastigmine in vascular dementia.
    Vincent S; Lane R
    Int Psychogeriatr; 2003; 15 Suppl 1():201-5. PubMed ID: 16191241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit.
    Giacobini E; Spiegel R; Enz A; Veroff AE; Cutler NR
    J Neural Transm (Vienna); 2002 Jul; 109(7-8):1053-65. PubMed ID: 12111443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease.
    Di Lazzaro V; Oliviero A; Pilato F; Saturno E; Dileone M; Marra C; Daniele A; Ghirlanda S; Gainotti G; Tonali PA
    J Neurol Neurosurg Psychiatry; 2004 Apr; 75(4):555-9. PubMed ID: 15026495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET.
    Kadir A; Darreh-Shori T; Almkvist O; Wall A; Långström B; Nordberg A
    Psychopharmacology (Berl); 2007 May; 191(4):1005-14. PubMed ID: 17310387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation.
    Di Lazzaro V; Oliviero A; Tonali PA; Marra C; Daniele A; Profice P; Saturno E; Pilato F; Masullo C; Rothwell JC
    Neurology; 2002 Aug; 59(3):392-7. PubMed ID: 12177373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic treatment with rivastigmine in patients with Alzheimer's disease: a study on primary motor cortex excitability tested by 5 Hz-repetitive transcranial magnetic stimulation.
    Trebbastoni A; Gilio F; D'Antonio F; Cambieri C; Ceccanti M; de Lena C; Inghilleri M
    Clin Neurophysiol; 2012 May; 123(5):902-9. PubMed ID: 21996001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of treatment response to rivastigmine in Alzheimer's dementia.
    Adler G; Brassen S; Chwalek K; Dieter B; Teufel M
    J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):292-4. PubMed ID: 14742608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic modulation of cortical plasticity in Alzheimer's disease patients.
    Koch G; Di Lorenzo F; Bonnì S; Giacobbe V; Bozzali M; Caltagirone C; Martorana A
    Neuropsychopharmacology; 2014 Oct; 39(11):2654-61. PubMed ID: 24859851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease.
    Stefanova E; Wall A; Almkvist O; Nilsson A; Forsberg A; Långström B; Nordberg A
    J Neural Transm (Vienna); 2006 Feb; 113(2):205-18. PubMed ID: 16049637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A large, naturalistic, community-based study of rivastigmine in mild-to-moderate AD: the EXTEND Study.
    Gauthier S; Juby A; Morelli L; Rehel B; Schecter R;
    Curr Med Res Opin; 2006 Nov; 22(11):2251-65. PubMed ID: 17076986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brain.
    Enz A; Gentsch C
    Neuropharmacology; 2004 Sep; 47(3):408-13. PubMed ID: 15275830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study.
    Aupperle PM; Koumaras B; Chen M; Rabinowicz A; Mirski D
    Curr Med Res Opin; 2004 Oct; 20(10):1605-12. PubMed ID: 15462693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months.
    Darreh-Shori T; Almkvist O; Guan ZZ; Garlind A; Strandberg B; Svensson AL; Soreq H; Hellström-Lindahl E; Nordberg A
    Neurology; 2002 Aug; 59(4):563-72. PubMed ID: 12196650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of switching from an AChE inhibitor to a dual AChE-BuChE inhibitor in patients with Alzheimer's disease.
    Bartorelli L; Giraldi C; Saccardo M; Cammarata S; Bottini G; Fasanaro AM; Trequattrini A;
    Curr Med Res Opin; 2005 Nov; 21(11):1809-18. PubMed ID: 16307702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rivastigmine in Alzheimer disease: efficacy over two years.
    Grossberg G; Irwin P; Satlin A; Mesenbrink P; Spiegel R
    Am J Geriatr Psychiatry; 2004; 12(4):420-31. PubMed ID: 15249280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of rivastigmine on cognitive functions and regional cerebral blood flow in Alzheimer's disease and vascular dementia: follow-up for 2 years].
    Lipczyńska-Łojkowska W; Ryglewicz D; Jedrzejczak T; Jakubowska T; Kotapka-Minc S; Sienkiewicz-Jarosz H; Bochyńska A
    Neurol Neurochir Pol; 2004; 38(6):471-81. PubMed ID: 15654671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of rivastigmine on caregiver burden associated with Alzheimer's disease in both informal care and nursing home settings.
    Grossberg GT
    Drugs Aging; 2008; 25(7):573-84. PubMed ID: 18582146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rivastigmine patch for treatment of Alzheimer's disease in clinical practice in Thailand.
    Kulkantrakorn K; Tanyakitpisal P; Towanabut S; Dejthevaporn C; Rangseekajee P; Pongpakdee S; Laptikultham S; Rodprasert K; Setthawatcharawanich S; Thinkhamrop B
    Psychogeriatrics; 2013 Mar; 13(1):1-8. PubMed ID: 23551405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients.
    Darreh-Shori T; Hellström-Lindahl E; Flores-Flores C; Guan ZZ; Soreq H; Nordberg A
    J Neurochem; 2004 Mar; 88(5):1102-13. PubMed ID: 15009666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.